93X Stock Overview
A nutraceutical company, engages in the development of nutritional products in Canada and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Promino Nutritional Sciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.029 |
| 52 Week High | CA$0.21 |
| 52 Week Low | CA$0.023 |
| Beta | 2.72 |
| 11 Month Change | 13.46% |
| 3 Month Change | -48.25% |
| 1 Year Change | -59.37% |
| 33 Year Change | -96.93% |
| 5 Year Change | n/a |
| Change since IPO | -98.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| 93X | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.6% | -1.5% |
| 1Y | -59.4% | -6.0% | 7.9% |
Return vs Industry: 93X underperformed the German Personal Products industry which returned -6% over the past year.
Return vs Market: 93X underperformed the German Market which returned 7.9% over the past year.
Price Volatility
| 93X volatility | |
|---|---|
| 93X Average Weekly Movement | 30.6% |
| Personal Products Industry Average Movement | 3.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 93X's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 93X's weekly volatility (31%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Vito Sanzone | www.elmtinc.com |
Promino Nutritional Sciences Inc., a nutraceutical company, engages in the development of nutritional products in Canada and the United States. The company offers Rejuvenate, a proprietary formulation to assist in the rebuilding, restoration, and rejuvenation of natural loss of muscle mass due to aging or other medical conditions; and protein powders and other nutritional supplements under Promino and JAKTRX brands for both professional and amateur athletes to accelerate muscle recovery, build strength, and accelerate recovery from injury. It also engages in retailing of its products through stores and online.
Promino Nutritional Sciences Inc. Fundamentals Summary
| 93X fundamental statistics | |
|---|---|
| Market cap | €3.47m |
| Earnings (TTM) | -€6.46m |
| Revenue (TTM) | €219.12k |
19.4x
P/S Ratio-0.7x
P/E RatioIs 93X overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 93X income statement (TTM) | |
|---|---|
| Revenue | CA$324.21k |
| Cost of Revenue | CA$1.82m |
| Gross Profit | -CA$1.50m |
| Other Expenses | CA$8.06m |
| Earnings | -CA$9.56m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.084 |
| Gross Margin | -461.57% |
| Net Profit Margin | -2,947.36% |
| Debt/Equity Ratio | -51.1% |
How did 93X perform over the long term?
See historical performance and comparison